Volume 6 Issue 10, October 1999

Letter to the Editor

• Farhad Hafezi
• Christian Grimm
• Charlotte E Remé

Letter to the Editor 20 Oct 1999

NO: an inhibitor of cell death

• Limin Liu
• Jonathan S Stamler

Review 20 Oct 1999

Neuronal protection and destruction by NO

• Stuart A Lipton

Review 20 Oct 1999

The anti-apoptotic actions of nitric oxide in hepatocytes

• Jianrong Li
• Timothy R Billiar

Review 20 Oct 1999

Nitric oxide and Drosophila development

• Grigori Enikolopov
• Julian Banerji
• Boris Kuzin

Review 20 Oct 1999

Nitric oxide–an endothelial cell survival factor

• Stefanie Dimmeler
• Andreas M Zeiher

Review 20 Oct 1999

Nitric oxide (NO): an effector of apoptosis

• Bernhard Brüne
• Andreas von Knethen
• Katrin B Sandau

Review 20 Oct 1999

The La (SS-B) autoantigen, a key protein in RNA biogenesis, is dephosphorylated and cleaved early during apoptosis

• Saskia A Rutjes
• Paul J Utz
• Ger JM Pruijn

Original Paper 20 Oct 1999

Activation of the JNK pathway is important for cardiomyocyte death in response to simulated ischemia

• Huaping He
• Hai-Ling Li
• Roberta A Gottlieb

Original Paper 20 Oct 1999

Tissue transglutaminase is a caspase substrate during apoptosis. Cleavage causes loss of transamidating function and is a biochemical marker of caspase 3 activation

• Marina Fabbi
• Danilo Marimpietri
• Elisabetta Cosulich

Original Paper 20 Oct 1999

Interleukin-15 is a potent survival factor in the prevention of spontaneous but not CD95-induced apoptosis in CD4 and CD8 T lymphocytes of HIV-infected individuals. Correlation with its ability to increase BCL-2 expression

• Honami Naora
• Marie-Lise Gougeon

Original Paper 20 Oct 1999

Differential expression of the IL-1 system components during in vitro myogenesis: Implication of IL-1β in induction of myogenic cell apoptosis

• François-Jérôme Authier
• Bénédicte Chazaud
• Romain K Gherardi

Original Paper 20 Oct 1999